# Debate Matchup Judgment Report

**Baidu Ernie 5.1** vs **Qwen 3.6 Max Preview**

- Paired result: **Qwen 3.6 Max Preview**
- Mean entertainment: `7.33 / 10`
- Judge decisions: `6` across two side-swapped debates

**Motion:** International rules should permit heritable human genome editing for serious monogenic diseases once safety thresholds are met.

## Debates and evidence

- [Debate A transcript](../../../transcripts/prop_0597__ernie-5.1__qwen3.6-max-preview__s0__tpl_placement_active_20260320f.md): PRO = **Baidu Ernie 5.1**, CON = **Qwen 3.6 Max Preview**
- [Debate B transcript](../../../transcripts/prop_0597__qwen3.6-max-preview__ernie-5.1__s1__tpl_placement_active_20260320f.md): PRO = **Qwen 3.6 Max Preview**, CON = **Baidu Ernie 5.1**
- [Public judge decision table](../../../judgments/judge_results__judge_blend_20260902_finala.csv)

## Debate A

- Transcript: [read the full debate](../../../transcripts/prop_0597__ernie-5.1__qwen3.6-max-preview__s0__tpl_placement_active_20260320f.md)
- Roles: PRO = **Baidu Ernie 5.1**, CON = **Qwen 3.6 Max Preview**
- Judged result: Unanimous `3-0` for **Qwen 3.6 Max Preview**.
- Entertainment scores: `8`, `7`, `7`
- Mean signed raw margin (PRO+): `-1.47`

| Judge | Presented sides | Winner | Signed Margin (PRO+) | Normalized | Entertainment |
| --- | --- | --- | ---: | ---: | ---: |
| GPT-5.5 (high) | A = Qwen 3.6 Max Preview (CON); B = Baidu Ernie 5.1 (PRO) | Qwen 3.6 Max Preview | -1.4 | -1.50 | 7.0 |
| Gemini 3.1 Pro Preview | A = Baidu Ernie 5.1 (PRO); B = Qwen 3.6 Max Preview (CON) | Qwen 3.6 Max Preview | -1.5 | -1.25 | 8.0 |
| Grok 4.3 | A = Qwen 3.6 Max Preview (CON); B = Baidu Ernie 5.1 (PRO) | Qwen 3.6 Max Preview | -1.5 | -1.80 | 7.0 |

### Judge Notes

- **GPT-5.5 (high)** (A = Qwen 3.6 Max Preview (CON); B = Baidu Ernie 5.1 (PRO)): Side A won by making the central safety assumption harder to accept: heritable edits create unrecallable, multigenerational risks that blastocyst sequencing, animal models, and registries cannot fully bound. Side B had a real benefit case for rare families and answered the questions in form, but leaned on overconfident claims about existing embryo results and regulation, while Side A persuasively weighed PGD, donor gametes, and somatic therapies as safer contained alternatives.
  Most decisive rebuttal noted: Side A's answer to Side B's homozygous-couple pressure was decisive: it conceded the hard case but reframed it as rare and not enough to justify irreversible germline risk merely to preserve a genetic link.
- **Gemini 3.1 Pro Preview** (A = Baidu Ernie 5.1 (PRO); B = Qwen 3.6 Max Preview (CON)): Side B won by successfully cornering Side A's necessity claim into a 'vanishingly rare' edge case (homozygous couples) and winning the comparative weighing between the desire for biological parentage and irreversible, population-level risk.
  Most decisive rebuttal noted: Side B's Rebuttal 2 answers to the pressure questions were decisive, specifically the argument that prioritizing genetic continuity over lineage safety inverts the precautionary principle.
- **Grok 4.3** (A = Qwen 3.6 Max Preview (CON); B = Baidu Ernie 5.1 (PRO)): CON won by establishing that multigenerational risks cannot be bounded by pre-implantation metrics, neutralizing PRO's necessity claim via donor gametes for the cited edge case, and exposing enforcement limits of registries against private clinics. PRO's responses on treaties and two-generation models added weaker, less responsive support.
  Most decisive rebuttal noted: A's direct A1/A2 answers to B's pressure questions on enforcement and late-onset effects, followed by weighing that shifted focus to irreversible population risk vs. outlier benefit.

## Debate B

- Transcript: [read the full debate](../../../transcripts/prop_0597__qwen3.6-max-preview__ernie-5.1__s1__tpl_placement_active_20260320f.md)
- Roles: PRO = **Qwen 3.6 Max Preview**, CON = **Baidu Ernie 5.1**
- Judged result: Split `2-1` for **Qwen 3.6 Max Preview**.
- Entertainment scores: `8`, `7`, `7`
- Mean signed raw margin (PRO+): `+0.53`

| Judge | Presented sides | Winner | Signed Margin (PRO+) | Normalized | Entertainment |
| --- | --- | --- | ---: | ---: | ---: |
| GPT-5.5 (high) | A = Baidu Ernie 5.1 (CON); B = Qwen 3.6 Max Preview (PRO) | Qwen 3.6 Max Preview | +1.6 | +1.71 | 7.0 |
| Gemini 3.1 Pro Preview | A = Qwen 3.6 Max Preview (PRO); B = Baidu Ernie 5.1 (CON) | Qwen 3.6 Max Preview | +1.5 | +1.25 | 8.0 |
| Grok 4.3 | A = Baidu Ernie 5.1 (CON); B = Qwen 3.6 Max Preview (PRO) | Baidu Ernie 5.1 | -1.5 | -1.80 | 7.0 |

### Judge Notes

- **GPT-5.5 (high)** (A = Baidu Ernie 5.1 (CON); B = Qwen 3.6 Max Preview (PRO)): B won by making the safety clause workable rather than impossible: medicine uses objective risk thresholds, not multigenerational certainty, and A never justified why only perfect lineage-level proof should count. B also gave the cleaner weighing on families with no disease-free embryos, regulatory permission reducing black markets, and binary serious monogenic limits being more auditable than enhancement. A’s strongest point was the unique irreversibility of germline edits, but it became repetitive and overclaimed that regulation cannot contain scope creep.
  Most decisive rebuttal noted: B’s answer that A’s multigenerational standard is a permanent veto, not a safety threshold, was decisive because it directly undercut A’s central route while preserving the motion’s conditional permission framework.
- **Gemini 3.1 Pro Preview** (A = Qwen 3.6 Max Preview (PRO); B = Baidu Ernie 5.1 (CON)): Side A successfully dismantles Side B's core argument that 'safety thresholds' require impossible multigenerational certainty. A achieves this by grounding the debate in how medical regulation actually works (preclinical metrics, off-target sequencing) and by using the human cloning ban to prove that international boundaries can hold. Side A also effectively distinguishes between the broad scope of IVF and the auditable, binary nature of monogenic diseases.
  Most decisive rebuttal noted: Side A's Rebuttal 2 effectively neutralizes the slippery slope argument by contrasting the broad nature of IVF (infertility) with the objective, auditable nature of monogenic diseases, while leveraging the successful ban on human cloning.
- **Grok 4.3** (A = Baidu Ernie 5.1 (CON); B = Qwen 3.6 Max Preview (PRO)): Side A wins by establishing that the proposition's safety threshold cannot be objectively satisfied for germline edits due to unavoidable multigenerational uncertainty, turning the conditional into a fiction; this line was never neutralized while distinguishing germline from IVF-style precedents. Side B's regulatory analogies and rarity arguments were answered directly and consistently.
  Most decisive rebuttal noted: Side A's answers in Rebuttal 2 to B's pressure questions cleanly isolated the irreversible, non-consensual nature of germline change, exposing why standard medical thresholds do not apply.

## Technical metadata

- Evaluation scope: `judge_judge_blend_20260902_finala__debate_all_templates`
- Topic ID: `prop_0597`
- Side-swap group ID: `prop_0597__ernie-5.1__qwen3.6-max-preview__tpl_placement_active_20260320f`
- Raw paired winner: **Qwen 3.6 Max Preview**
- Mean normalized margin for Baidu Ernie 5.1: `-0.95`
- Complete side swap: `yes`
- Included in ratings: `yes`
